Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.310 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
SLDB | Solid Biosciences | 5.04 | -0.13 | -2.51% | 555.1M |
You can purchase shares of Solid Biosciences (NASDAQ: SLDB) through any online brokerage.
Other companies in Solid Biosciences’s space includes: 89bio (NASDAQ:ETNB), Chinook Therapeutics (NASDAQ:KDNY) and Eagle Pharmaceuticals (NASDAQ:EGRX).
The latest price target for Solid Biosciences (NASDAQ: SLDB) was reported by Chardan Capital on 2021-03-16. The analyst firm set a price target for 20.00 expecting SLDB to rise to within 12 months (a possible 296.83% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Solid Biosciences (NASDAQ: SLDB) is $5.04 last updated Fri Apr 16 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Solid Biosciences.
There is no upcoming split for Solid Biosciences.